Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCND3 | P30281 | 7/20 | 0.79 |
| ▸ | CDK6 | Q00534 | 7/20 | 0.79 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.73 |
| ▸ | CCNK | O75909 | 4/20 | 0.66 |
| ▸ | CDK9 | P50750 | 4/20 | 0.66 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.66 |
| ▸ | JAK3 | P52333 | 2/20 | 0.63 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.63 |
| ▸ | CDK2 | P24941 | 2/20 | 0.63 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.62 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.62 |
| ▸ | TNK2 | Q07912 | 3/20 | 0.61 |
| ▸ | STAT6 | P42226 | 1/20 | 0.61 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.61 |
| ▸ | JAK2 | O60674 | 1/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.61 |
| ▸ | LCK | P06239 | 1/20 | 0.61 |
| ▸ | ROS1 | P08922 | 1/20 | 0.61 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.61 |
| ▸ | SRC | P12931 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24255231 | 0.91 | NTRK1 (0.81) | CCND3CDK6NTRK1CCNKCDK9 | |
| SCHEMBL30393724 | 0.88 | CCND3 (1.00) | CCND3CDK6NTRK1CCNKCDK9 | |
| SCHEMBL17209773 | 0.85 | JAK3 (0.83) | NTRK1JAK3JAK2FGFR1SRC | |
| SCHEMBL24255221 | 0.83 | JAK3 (0.75) | CCND3CDK6ALKJAK3TNK2 | |
| SCHEMBL18487871 | 0.83 | NTRK1 (0.64) | CCND3CDK6NTRK1CCNKCDK9 | |
| SCHEMBL18488287 | 0.81 | CCND3 (0.80) | CCND3CDK6NTRK1CCNKCDK9 | |
| SCHEMBL24255245 | 0.81 | NTRK1 (0.66) | CCND3CDK6NTRK1ALKJAK3 | |
| SCHEMBL18440651 | 0.81 | ALK (0.74) | CCND3CDK6NTRK1CCNKCDK9 | |
| SCHEMBL1607209 | 0.81 | ALK (0.67) | CCND3CDK6NTRK1CCNKCDK9 | |
| SCHEMBL23409133 | 0.80 | ALK (0.72) | CCND3CDK6NTRK1CCNKCDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295129-A1 | INHIBITORS OF ACK1/TNK2 TYROSINE KINASE | NATIONAL INSTITUTES OF HEALTH | 2023-09-21 | — | — | US | disclosed |
| US-20230295129-A1 | INHIBITORS OF ACK1/TNK2 TYROSINE KINASE | NATIONAL INSTITUTES OF HEALTH | 2023-09-21 | — | — | US | disclosed |
| WO-2022036312-A2 | INHIBITORS OF ACK1/TNK1 TYROSINE KINASE | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295129-A1 | INHIBITORS OF ACK1/TNK2 TYROSINE KINASE | TNK1, TNK2, TNNI3K | CCND3 1813/4885CDK6 398/4885NTRK1 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.